News Detail
New Delhi, 11 Jan 2021: Serum Institute of India (SII) has received a purchase order from the Central government for 11 million doses of Covishield, the company officials said today.
Oxford vaccine Covishield, being manufactured by the Serum Institute, will......
View Details
Source : CNBCTV18
Related News
- COVID-19 vaccination will be allowed at home in future (27-02-2021)
- Pfizer COVID-19 vaccine reduces transmission after one dose - UK study (27-02-2021)
- Gujarat FDCA registers 5 lakhs product licenses, 4,880 mfg licences through DMLA software (27-02-2021)
- Guidelines for pharma PLI scheme to be out by March: Secy (27-02-2021)
- Govt may notify revised list of essential medicines by March-end (27-02-2021)
- Substandard antibiotics seized in Andhra, probe underway (27-02-2021)
- Oxford University Covid-19 lab suffers cyberattack (26-02-2021)
- Coronil controversy: IMA asks Patanjali to furnish documents (26-02-2021)
- Govt working to reduce regulatory compliance burden on pharma sector: Sadananda Gowda (26-02-2021)
- IPC signs MoU with BPC for knowledge sharing on pharmacopoeial standards (26-02-2021)